This paper has researched on six kinds of the corporate DNA models, which have set up and analyzed its limitations, regarded the corporation as a vital organism, and put forward the judging standard for corporate DNA ...This paper has researched on six kinds of the corporate DNA models, which have set up and analyzed its limitations, regarded the corporation as a vital organism, and put forward the judging standard for corporate DNA by analogism. According to the standard, the components of the corporate DNA are judged and a new model has been established. The corporate DNA is composed of four DNA chains, which overlap and intercross in the model. Based on the new model, the concept of the corporate central dogma is put forward. The element and information transmission way of corporate information are discussed in the corporate central dogma.展开更多
AIM：To survey ophthalmologists（who have participated previously in clinical research） and ophthalmic industry professionals（who have been involved in ocular research and development） to indicate perceived needs f...AIM：To survey ophthalmologists（who have participated previously in clinical research） and ophthalmic industry professionals（who have been involved in ocular research and development） to indicate perceived needs for new pharmaceuticals in various ophthalmic subspecialties.METHODS：A prospective,industry-based survey was sent to ophthalmologists and ophthalmic industry professionals about the perceived needs for new pharmaceutical products.RESULTS：This survey was sent to 559 ophthalmic pharma professionals and ophthalmologists.We received 82（15%） responses.The results showed that the most commonly perceived need for new pharmaceuticals were dry and wet age-related macular degeneration,glaucoma,diabetic macular edema and dry eye.There was a statistical difference found between response groups（P〈0.0001）.Respondents indicated they would express their commitment to a new product they perceived as needed by recommending to colleagues（63%）,prescribing（60%）,participating as principle investigator in a related clinical trial（52%）,advising the company（52%）,lecturing on behalf of the product（43%）,investing in the product（38%）,taking no action（7%） or obtain a position in the company（1%）.CONCLUSION：Ophthalmic pharma professionals and ophthalmologists perceive the greatest need for new medicines in ophthalmology to be in dry and wet agerelated macular degeneration,glaucoma,diabetic macular edema and dry eye.展开更多
Social responsibility investment(SRI)has gradually become a new investment concept in the world.In the context of the new era,SRI has such problems in China such as lack of sufficient policy guarantee,SRI awareness of...Social responsibility investment(SRI)has gradually become a new investment concept in the world.In the context of the new era,SRI has such problems in China such as lack of sufficient policy guarantee,SRI awareness of investors and evaluation awareness of consumers on corporate social responsibility(CSR),and low degree of information disclosure of CSR.This paper puts forward some countermeasures to improve policies,laws and regulations on SRI in China,as well as the information disclosure system of social responsibility.This paper discusses enlightenment of the research progress of foreign SRI to China to promote the further development of SRI in China.展开更多
文摘This paper has researched on six kinds of the corporate DNA models, which have set up and analyzed its limitations, regarded the corporation as a vital organism, and put forward the judging standard for corporate DNA by analogism. According to the standard, the components of the corporate DNA are judged and a new model has been established. The corporate DNA is composed of four DNA chains, which overlap and intercross in the model. Based on the new model, the concept of the corporate central dogma is put forward. The element and information transmission way of corporate information are discussed in the corporate central dogma.
文摘AIM：To survey ophthalmologists（who have participated previously in clinical research） and ophthalmic industry professionals（who have been involved in ocular research and development） to indicate perceived needs for new pharmaceuticals in various ophthalmic subspecialties.METHODS：A prospective,industry-based survey was sent to ophthalmologists and ophthalmic industry professionals about the perceived needs for new pharmaceutical products.RESULTS：This survey was sent to 559 ophthalmic pharma professionals and ophthalmologists.We received 82（15%） responses.The results showed that the most commonly perceived need for new pharmaceuticals were dry and wet age-related macular degeneration,glaucoma,diabetic macular edema and dry eye.There was a statistical difference found between response groups（P〈0.0001）.Respondents indicated they would express their commitment to a new product they perceived as needed by recommending to colleagues（63%）,prescribing（60%）,participating as principle investigator in a related clinical trial（52%）,advising the company（52%）,lecturing on behalf of the product（43%）,investing in the product（38%）,taking no action（7%） or obtain a position in the company（1%）.CONCLUSION：Ophthalmic pharma professionals and ophthalmologists perceive the greatest need for new medicines in ophthalmology to be in dry and wet agerelated macular degeneration,glaucoma,diabetic macular edema and dry eye.
文摘Social responsibility investment(SRI)has gradually become a new investment concept in the world.In the context of the new era,SRI has such problems in China such as lack of sufficient policy guarantee,SRI awareness of investors and evaluation awareness of consumers on corporate social responsibility(CSR),and low degree of information disclosure of CSR.This paper puts forward some countermeasures to improve policies,laws and regulations on SRI in China,as well as the information disclosure system of social responsibility.This paper discusses enlightenment of the research progress of foreign SRI to China to promote the further development of SRI in China.
